Related Experiment Video
Updated: Dec 25, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Ventilator-associated pneumonia in patients with cerebral hemorrhage: Impact on mortality and microbiological
Lu Yu Xue1, Saren Gaowa1, Wei Wang1
1Department of Intensive Care Unit, Huashan Hospital, Fudan University, Shanghai, China.
Abstract:
Ventilator-associated pneumonia (VAP) is a major complication among critically ill patients who depend on mechanical ventilation. Few reports have focused on intracerebral hemorrhage patients with VAP. Our main objective was to investigate the bacteria distribution characteristics and the impact of ventilator-associated pneumonia mortality in critical cerebral hemorrhage patients. This retrospective study included 89 cases of cerebral hemorrhage patients with VAP admitted to the ICU of Huashan Hospital. We used the chi-square test to compare qualitative variables and Student's t-test to compare means between groups of normally distributed quantitative variables. Multiple logistic regression analysis was used to assess mortality-independent predictors in the ICU. A total of 42% patients with cerebral hemorrhage were diagnosed with VAP in the ICU during the study period, and the mortality rate was 18%. Acinetobacter baumannii (n=58), Klebsiella pneumoniae (n=52), and Pseudomonas aeruginosa (n=21) were the most common pathogenic bacteria. Blood volume >30ml, tracheal ventilation mode and head of bed elevation were independent factors associated with increased mortality. Glasgow Coma Scale (GCS), Acute Physiology and Chronic Health Evaluation II (APACHE II) score and the time from bleeding to intubation were other potentially important factors. While the number of infecting bacteria may not be directly related to death, it can increase antibiotic consumption and length of intensive care unit (ICU) stays. Blood volume >30ml, tracheal ventilation mode and head of bed elevation were directly related to the death of critical cerebral hemorrhage patients with ventilator-associated pneumonia.
Insights
Ventilator-associated pneumonia (VAP) in critical cerebral hemorrhage patients is common, with Acinetobacter baumannii being a frequent pathogen. Factors like large blood volume and head elevation increase mortality risk.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Neurology
Background:
- Ventilator-associated pneumonia (VAP) is a significant complication in critically ill patients requiring mechanical ventilation.
- Limited research exists on VAP specifically within the context of intracerebral hemorrhage (ICH).
Purpose of the Study:
- To determine the bacterial distribution and identify mortality predictors in ICH patients with VAP.
- To analyze the impact of VAP on mortality rates in this specific patient population.
Main Methods:
- Retrospective study of 89 ICH patients with VAP in an ICU.
- Statistical analysis including chi-square test, Student's t-test, and multiple logistic regression.
- Identification of common pathogens and independent mortality factors.
Main Results:
- 42% of ICH patients developed VAP, with an 18% mortality rate.
- Common pathogens included Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
- Increased blood volume (>30ml), tracheal ventilation, and head of bed elevation were independent risk factors for mortality.
Conclusions:
- VAP is prevalent in ICH patients and associated with significant mortality.
- Specific clinical factors (blood volume, ventilation mode, bed elevation) are directly linked to increased mortality.
- While bacterial load may not directly cause death, it impacts resource utilization like antibiotics and ICU stay.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:223D Cine Magnetic Resonance Imaging of Respiratory Motion in Mechanically Ventilated Mice and Rats
Published on: September 19, 2025
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Mechanical Ventilation I: Indication and Settings